skinny.

Latest / Dothan News Today | 2 Min News | The Daily News Now!

FDA Approves Groundbreaking Pancreatic Cancer Pill | Dothan News

FDA just approved a groundbreaking new pill for advanced pancreatic cancer — the first in years to target the RAS protein, which drives tumor growth. Called Rasonque, it’s a once-daily treatment that doubled survival time in trials, giving patients nearly 13 months compared to just 6.7 with chemo. Approved ahead of schedule with special fast-track designations, it’s a major leap forward for a disease long considered untreatable. Side effects include rash and nausea, but for patients with limited options, this is a ray of hope. Listen in comfort:Get a discount on a Soli Pillow…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.